hc1 Brings Speed, Precision, and Vision to HLTH 2026
The lab intelligence leader transforms Booth #1559 into the show's can't-miss stop, featuring a track ready IndyCar,
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.
![]()
hc1®, the industry leader in AI-powered lab diagnostic intelligence and a 2026 honoree on TIME’s World’s Top HealthTech Companies, today announced a comprehensive presence at HLTH USA 2026, taking place November 15–18 at The Venetian Expo in Las Vegas. From Booth #1559 in the Diagnostics Zone, hc1 will deliver a complete expression of its platform, data assets, and thought leadership for every type of attendee at the show.
At the center of Booth #1559, hc1 is showcasing the hc1 IQ™ platform, an AI-powered ecosystem unifying clinical intelligence, operational analytics, supply chain optimization, and market growth into real-time lab intelligence. Built on more than 12 billion lab results across 350+ provider sites, hc1 IQ™ comprises four integrated products: Clinical IQ™, Ops IQ™, Source IQ™, and Signal IQ™. Attendees can see the platform live throughout the conference.
Anchoring the Diagnostics Zone is a life-size IndyCar, finished in hc1’s signature livery, representing the No. 24 car hc1 sponsored at the 2026 Indianapolis 500. Rather than speed, the car reflects the precision and discipline hc1 brings to every data point moving through its platform and is billed as “Not Your Typical Booth Experience.”
The independently produced Boombostic Health Podcast, hosted by hc1 Chairman and CEO Bradley Bostic, will record live from Booth #1559 throughout HLTH, featuring conversations with healthcare executives and innovators.
Bostic will also take the main stage on Tuesday, November 17, from 3:05–3:50 p.m. in AI Theater A of the AI Zone for the panel “AI and the Care Team: Augmenting Nurses, Specialists, and Frontline Staff Without Replacing Judgment.” Moderated by Karen Brown, PharmD, the session also features Christine Landry of Kyndryl and Dr. James Geracci, MD, of Lumeris.
“The lab generates the most objective, time-sensitive signals in all of healthcare, and hc1 IQ™ puts that intelligence in front of the right people at the exact moment of decision,” said Bradley Bostic, Chairman and CEO of hc1 and 2026 IBJ CEO of the Year honoree. “From an IndyCar on the show floor to live hc1 IQ™ demos, a main-stage panel on AI and the care team, and live Boombostic Health Podcast recordings from Booth #1559, every element of our presence points to the same truth: hc1 is a force multiplier for clinicians, operators, and leaders working to deliver better care.”
About hc1
hc1 is the industry leader in lab intelligence, turning diagnostic data into real-time, actionable insight for health systems, payers, pharma, and life sciences organizations. Through the AI-powered hc1 IQ™ platform, that powers Clinical IQ™, Ops IQ™, Source IQ™, and Signal IQ™, hc1 helps leaders control costs, streamline operations, close care gaps, and unlock the value of real-world data, all at the speed of care. hc1 was named to TIME’s World’s Top HealthTech Companies of 2026. Learn how hc1 is revolutionizing healthcare at www.hc1.ai.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261112952795/en/
Media gallery